By analyzing the immunohistochemical images and immunoreactive scores of BMP-2, CD44, and Rb proteins in each sample, we confirmed that BMP-2 expression was positively correlated with CD44 expression in the breast carcinoma cohort (Figures 5a and b, Supplementary Figure 2). The gene discussed is CD44; the disease is breast carcinoma.